294 related articles for article (PubMed ID: 22640988)
21. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
[TBL] [Abstract][Full Text] [Related]
22. SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.
Lietman SA; Yin L; Levine MA
J Orthop Res; 2010 Nov; 28(11):1425-30. PubMed ID: 20872577
[TBL] [Abstract][Full Text] [Related]
23. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
[TBL] [Abstract][Full Text] [Related]
24. A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family.
Dinckan N; Guven Y; Kayserili H; Aktoren O; Uyguner OZ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e42-6. PubMed ID: 23083484
[TBL] [Abstract][Full Text] [Related]
25. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
[TBL] [Abstract][Full Text] [Related]
26. Autoinflammatory bone disorders.
Ferguson PJ; El-Shanti HI
Curr Opin Rheumatol; 2007 Sep; 19(5):492-8. PubMed ID: 17762617
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
[TBL] [Abstract][Full Text] [Related]
28. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
Deckert M; Prod'Homme V
Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
[No Abstract] [Full Text] [Related]
29. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.
Carvalho VM; Perdigão PF; Amaral FR; de Souza PE; De Marco L; Gomez RS
Oral Dis; 2009 Jan; 15(1):106-10. PubMed ID: 19017279
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the SH3BP2 gene in 2 families of cherubism.
Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
[TBL] [Abstract][Full Text] [Related]
31. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
Teixeira RC; Horz HP; Damante JH; Garlet GP; Santos CF; Nogueira RL; Cavalcante RB; Conrads G
Int J Oral Maxillofac Surg; 2011 Aug; 40(8):851-5. PubMed ID: 21680150
[TBL] [Abstract][Full Text] [Related]
32. Cherubism: best clinical practice.
Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
[TBL] [Abstract][Full Text] [Related]
33. Investigating global gene expression changes in a murine model of cherubism.
Sharma T; Cotney J; Singh V; Sanjay A; Reichenberger EJ; Ueki Y; Maye P
Bone; 2020 Jun; 135():115315. PubMed ID: 32165349
[TBL] [Abstract][Full Text] [Related]
34. SH3BP2 is an activator of NFAT activity and osteoclastogenesis.
Lietman SA; Yin L; Levine MA
Biochem Biophys Res Commun; 2008 Jul; 371(4):644-8. PubMed ID: 18440306
[TBL] [Abstract][Full Text] [Related]
35. Decreased SH3BP2 inhibits osteoclast differentiation and function.
Kawamoto T; Fan C; Gaivin RJ; Levine MA; Lietman SA
J Orthop Res; 2011 Oct; 29(10):1521-7. PubMed ID: 21448930
[TBL] [Abstract][Full Text] [Related]
36. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.
Aliprantis AO; Ueki Y; Sulyanto R; Park A; Sigrist KS; Sharma SM; Ostrowski MC; Olsen BR; Glimcher LH
J Clin Invest; 2008 Nov; 118(11):3775-89. PubMed ID: 18846253
[TBL] [Abstract][Full Text] [Related]
37. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.
de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
Br J Oral Maxillofac Surg; 2007 Sep; 45(6):499-500. PubMed ID: 16713042
[TBL] [Abstract][Full Text] [Related]
38. Cherubism: a systematic literature review of clinical and molecular aspects.
Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
[TBL] [Abstract][Full Text] [Related]
40. A novel mutation in the SH3BP2 gene causes cherubism: case report.
Li CY; Yu SF
BMC Med Genet; 2006 Dec; 7():84. PubMed ID: 17147794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]